/
/
/

Gufic Biosciences Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---15%
----8%
27%18%11%21%
13%13%13%10%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
GUFICBIO
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,916₹463791 Cr38.3412.0762.82₹11479 Cr
9,250₹245081 Cr83.7934.04128.41₹2568 Cr
4,905.5₹190351 Cr87.2816.7297.06₹2163 Cr
1,143₹114833 Cr25.449.4262.53₹5040 Cr
1,394.7₹114163 Cr33.879.7757.87₹3879 Cr
1,868.5₹100660 Cr92.066.829.25₹889 Cr
2,132₹98431 Cr17.830.95154.36₹5333 Cr
2,368.8₹98305 Cr48.1313.7571.08₹1913 Cr
1,155₹96906 Cr30.075.3263.99₹4196 Cr
1,637.3₹95300 Cr25.6717.9596.84₹3505 Cr
439.35₹4405 Cr59.972.2310.4₹64 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹261 Cr₹252 Cr₹231 Cr₹237 Cr₹224 Cr₹205 Cr₹208 Cr₹204 Cr₹203 Cr₹195 Cr₹202 Cr₹215 Cr
₹46 L-₹1 Cr₹79 L₹2 Cr₹93 L₹39 L₹2 Cr₹11 L₹1 Cr₹88 L₹42 L₹33 L
₹261 Cr₹251 Cr₹232 Cr₹239 Cr₹225 Cr₹205 Cr₹210 Cr₹204 Cr₹204 Cr₹196 Cr₹202 Cr₹215 Cr
₹222 Cr₹212 Cr₹206 Cr₹207 Cr₹198 Cr₹186 Cr₹178 Cr₹170 Cr₹171 Cr₹165 Cr₹169 Cr₹180 Cr
₹47 Cr₹46 Cr₹34 Cr₹40 Cr₹34 Cr₹27 Cr₹36 Cr₹39 Cr₹37 Cr₹35 Cr₹37 Cr₹40 Cr
₹9 Cr₹9 Cr₹8 Cr₹10 Cr₹9 Cr₹8 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr
₹30 Cr₹29 Cr₹18 Cr₹23 Cr₹17 Cr₹11 Cr₹26 Cr₹29 Cr₹28 Cr₹27 Cr₹30 Cr₹31 Cr
₹22 Cr₹22 Cr₹12 Cr₹17 Cr₹13 Cr₹8 Cr₹19 Cr₹22 Cr₹21 Cr₹20 Cr₹22 Cr₹23 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024
₹10 Cr₹10 Cr₹10 Cr
₹0₹10 L₹0
₹655 Cr₹591 Cr₹523 Cr
₹655 Cr₹591 Cr₹523 Cr
₹665 Cr₹601 Cr₹533 Cr
₹4 L₹0₹0
₹105 Cr₹131 Cr₹154 Cr
₹17 Cr₹8 Cr₹2 Cr
₹20 Cr₹25 Cr₹17 Cr
₹18 Cr₹17 Cr₹15 Cr
₹160 Cr₹181 Cr₹188 Cr
₹199 Cr₹159 Cr₹166 Cr
₹58 Cr₹70 Cr₹56 Cr
₹254 Cr₹154 Cr₹142 Cr
₹6 Cr₹4 Cr₹7 Cr
₹518 Cr₹388 Cr₹372 Cr
₹1342 Cr₹1169 Cr₹1093 Cr
₹12 Cr₹6 Cr₹7 Cr
₹385 Cr₹310 Cr₹317 Cr
₹630 Cr₹614 Cr₹246 Cr
₹139 Cr₹108 Cr₹87 Cr
₹491 Cr₹506 Cr₹159 Cr
₹22 Cr₹22 Cr₹307 Cr
₹2 Cr₹2 Cr₹2 Cr
₹2 Cr₹2 Cr₹2 Cr
₹24 Cr₹13 Cr₹23 Cr
₹2 Cr₹2 Cr₹1 Cr
₹540 Cr₹545 Cr₹492 Cr
₹324 Cr₹217 Cr₹200 Cr
₹297 Cr₹315 Cr₹330 Cr
₹76 Cr₹29 Cr₹13 Cr
₹2 Cr₹2 Cr₹4 Cr
₹102 Cr₹63 Cr₹53 Cr
₹802 Cr₹625 Cr₹600 Cr
₹284 Cr₹237 Cr₹228 Cr
₹1342 Cr₹1169 Cr₹1093 Cr
₹66₹60₹53
₹66₹60₹53

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024
₹87 Cr₹94 Cr₹116 Cr
₹65 Cr₹44 Cr₹34 Cr
-₹95 Cr₹7 Cr-₹130 Cr
₹57 Cr₹145 Cr₹20 Cr
₹45 Cr₹123 Cr-₹7 Cr
-₹31 Cr-₹71 Cr-₹102 Cr
₹32 Cr-₹37 Cr₹82 Cr
₹46 Cr₹15 Cr-₹27 Cr
₹16 Cr₹1 Cr₹29 Cr
₹62 Cr₹16 Cr₹1 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)440.50
Volume (₹)42,917.00
High (₹)447.20
Upper Circuit527.20
Low (₹)437.15
Lower Circuit351.50
Prev Close439.35
52W High (₹)453.95
Price440.10
52W Low (₹)268.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4414.94 Cr
Div. Yield (%)0.02
PE Ratio60.10
Debt to Equity0.58
Price to Book4.14
Book Value66.31
EPS (TTM)7.33
Face Value1.00
ROE (%)10.14

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
GUFICBIONSE
LTP
1W Low
1W High
Market cap (₹)
1901.6-18.4 (-0.96%)
1900.10
1984.80
4,56,833Cr
9180.5-58.5 (-0.63%)
9087
9467
2,45,426Cr
4861.5-188.5 (-3.73%)
4857
5066
1,87,320Cr
1131.4-59.6 (-5.00%)
1125.10
1187
1,13,217Cr
1380.7-42.8 (-3.01%)
1376.70
1426.10
1,12,212Cr
1852.9-85.6 (-4.42%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2335.2-47.7 (-2.00%)
2335
2419.20
96,859Cr
1162-16 (-1.36%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
440.1+33.8 (8.32%)
395.05
453.95
4,415Cr

Gufic Biosciences Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹47.06Cr; with other income of ₹45.8Lakh, profit before interest and tax came to ₹39.36Cr. Interest expense was ₹9.32Cr; PBT before exceptional items stood at ₹30.04Cr. Cost mix (full year): raw materials ₹418.02Cr; employee cost ₹151.68Cr; depreciation ₹7.71Cr; other expenses ₹214.21Cr. Basis: consolidated annual results.

Gufic Biosciences Ltd Quaterly Results Key Takeaways

Gufic Biosciences Ltd reported ₹260.82Cr total income from operations in Jun 2026, softer than ₹251.82Cr in Mar 2026 but higher than ₹223.72Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹47.06Cr; with other income of ₹45.8Lakh, profit before interest and tax came to ₹39.36Cr. Interest expense was ₹9.32Cr, taking profit before tax to ₹30.04Cr. After tax of ₹7.73Cr, profit after tax stood at ₹22.31Cr (vs ₹21.9Cr in Mar 2026 and ₹13.07Cr in Jun 2025).